Common Contracts

Memorandum of Understanding Provision of Investigational Drug Through Expanded Access – Treatment of COVID-19 Related Diseases

Instructions • March 19th, 2020

• Contract Type
  Instructions
• Filed
  March 19th, 2020

This Memorandum of Understanding (this “MOU”) by and between <Name of Manufacturer of Investigational Drug> (“Company”) and <Name of Institution> (“Institution”) is effective as of [ _____ ], 2020 (the “Effective Date”). The purpose of this MOU is to memorialize the parties’ mutual understandings with respect to the provision of <Investigational Drug> (the “Investigational Drug”) by Company to Institution for patient treatment of COVID-19 related diseases pursuant to the attached treatment plan or protocol (the “Plan”).